These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26073995)

  • 1. Development of a stable low-dose aglycosylated antibody formulation to minimize protein loss during intravenous administration.
    Morar-Mitrica S; Puri M; Beumer Sassi A; Fuller J; Hu P; Crotts G; Nesta D
    MAbs; 2015; 7(4):792-803. PubMed ID: 26073995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration.
    Glover ZW; Gennaro L; Yadav S; Demeule B; Wong PY; Sreedhara A
    J Pharm Sci; 2013 Mar; 102(3):794-812. PubMed ID: 23225178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Full-length recombinant antibodies from
    Rashid MH
    MAbs; 2022; 14(1):2111748. PubMed ID: 36018829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags.
    Hui A; Yin J; Liu W; Zheng K
    Int J Pharm Compd; 2021; 25(3):246-257. PubMed ID: 34125716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and characterization of CHO host cell protease-induced fragmentation of a recombinant monoclonal antibody during production process development.
    Yang B; Li W; Zhao H; Wang A; Lei Y; Xie Q; Xiong S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Apr; 1112():1-10. PubMed ID: 30836312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells.
    Reusch U; Duell J; Ellwanger K; Herbrecht C; Knackmuss SH; Fucek I; Eser M; McAleese F; Molkenthin V; Gall FL; Topp M; Little M; Zhukovsky EA
    MAbs; 2015; 7(3):584-604. PubMed ID: 25875246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility, physical stability, and characterization of an IgG4 monoclonal antibody after dilution into different intravenous administration bags.
    Kumru OS; Liu J; Ji JA; Cheng W; Wang YJ; Wang T; Joshi SB; Middaugh CR; Volkin DB
    J Pharm Sci; 2012 Oct; 101(10):3636-50. PubMed ID: 22733600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Edetate Disodium as a Polysorbate Degradation and Monoclonal Antibody Oxidation Stabilizer.
    Yarbrough M; Hodge T; Menard D; Jerome R; Ryczek J; Moore D; Baldus P; Warne N; Ohtake S
    J Pharm Sci; 2019 Apr; 108(4):1631-1635. PubMed ID: 30502482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new tool for monoclonal antibody analysis: application of IdeS proteolysis in IgG domain-specific characterization.
    An Y; Zhang Y; Mueller HM; Shameem M; Chen X
    MAbs; 2014; 6(4):879-93. PubMed ID: 24927271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Polysorbate 80 Hydrolysis and Oxidation on the Aggregation of a Monoclonal Antibody.
    Larson NR; Wei Y; Prajapati I; Chakraborty A; Peters B; Kalonia C; Hudak S; Choudhary S; Esfandiary R; Dhar P; Schöneich C; Middaugh CR
    J Pharm Sci; 2020 Jan; 109(1):633-639. PubMed ID: 31758949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of monoclonal antibody fragments cleaved at the complementarity determining region using orthogonal analytical methods.
    Li W; Yang B; Zhou D; Xu J; Li W; Suen WC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1048():121-129. PubMed ID: 28242491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of pH on heat-induced aggregation and degradation of therapeutic monoclonal antibodies.
    Ishikawa T; Ito T; Endo R; Nakagawa K; Sawa E; Wakamatsu K
    Biol Pharm Bull; 2010; 33(8):1413-7. PubMed ID: 20686240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical and structural stability of the monoclonal antibody, trastuzumab (Herceptin®), intravenous solutions.
    Pabari RM; Ryan B; Ahmad W; Ramtoola Z
    Curr Pharm Biotechnol; 2013; 14(2):220-5. PubMed ID: 23360264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of monoclonal antibody size variants containing extra light chains.
    Lu C; Liu D; Liu H; Motchnik P
    MAbs; 2013; 5(1):102-13. PubMed ID: 23255003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of subclass change on the structural stability of chimeric, humanized, and human antibodies under thermal stress.
    Ito T; Tsumoto K
    Protein Sci; 2013 Nov; 22(11):1542-51. PubMed ID: 23963869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Acyl-Protein Thioesterase-1 as a Polysorbate-Degrading Host Cell Protein in a Monoclonal Antibody Formulation Using Activity-Based Protein Profiling.
    Šprager E; Möller J; Lin Y; Reisinger V; Bratkovič T; Lunder M; Vašl J; Krajnc A
    J Pharm Sci; 2024 Aug; 113(8):2128-2139. PubMed ID: 38772451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Polysorbate Ester Fractions and Implications in Protein Drug Product Stability.
    Tomlinson A; Zarraga IE; Demeule B
    Mol Pharm; 2020 Jul; 17(7):2345-2353. PubMed ID: 32442382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of cysteine-linked conjugation profiles of immunoglobulin G1 and immunoglobulin G2 antibody-drug conjugates.
    Wiggins B; Liu-Shin L; Yamaguchi H; Ratnaswamy G
    J Pharm Sci; 2015 Apr; 104(4):1362-72. PubMed ID: 25631158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polysorbates 20 and 80 Degradation by Group XV Lysosomal Phospholipase A2 Isomer X1 in Monoclonal Antibody Formulations.
    Hall T; Sandefur SL; Frye CC; Tuley TL; Huang L
    J Pharm Sci; 2016 May; 105(5):1633-1642. PubMed ID: 27056628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.
    Reusch D; Haberger M; Falck D; Peter B; Maier B; Gassner J; Hook M; Wagner K; Bonnington L; Bulau P; Wuhrer M
    MAbs; 2015; 7(4):732-42. PubMed ID: 25996192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.